Who Exports Secnidazole from India — 115 Suppliers Behind a $30.3M Market
India's secnidazole export market is supplied by 115 active exporters who collectively shipped $30.3M across 652 shipments. CAPLIN POINT LABORATORIES LIMITED leads with a 54.0% market share, followed by LINCOLN PHARMACEUTICALS LTD and AJANTA PHARMA LIMITED. The top 5 suppliers together control 84.6% of total export value, reflecting a concentrated market structure.
Top Secnidazole Exporters from India — Ranked by Export Value
CAPLIN POINT LABORATORIES LIMITED is the leading secnidazole exporter from India, holding a 54.0% share of the $30.3M market across 652 shipments from 115 exporters. The top 5 suppliers — CAPLIN POINT LABORATORIES LIMITED, LINCOLN PHARMACEUTICALS LTD, AJANTA PHARMA LIMITED, ATHENA DRUG DELIVERY SOLUTIONS PRIVATE LIMITED, CIPLA LIMITED — collectively control 84.6% of total export value, indicating a highly concentrated market. Individual shares are: CAPLIN POINT LABORATORIES LIMITED (54.0%), LINCOLN PHARMACEUTICALS LTD (18.0%), AJANTA PHARMA LIMITED (6.7%), ATHENA DRUG DELIVERY SOLUTIONS PRIVATE LIMITED (3.6%), CIPLA LIMITED (2.3%).
Top Secnidazole Exporters from India
Ranked by export value · 115 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | CAPLIN POINT LABORATORIES LIMITED SECNIDAZOLE TABLETS 500MGSECNIDAZOLE TABLETS 500 MGSECNIDAZOLE FOR ORAL SUSPENSION 125MG/5M | $16.4M | 4 | 54.0% |
| 2 | LINCOLN PHARMACEUTICALS LTD SECNIDAZOLE TABLETS BP 1000 MG (14PHARMACEUTICAL PRODUCTS : SENIDOL SECNIDAZOLE TABLETS 1GMTAGERA FORTE TABLETS SECNIDAZOLE 1G TABLETS 10X1X2T PACKS | $5.5M | 5 | 18.0% |
| 3 | AJANTA PHARMA LIMITED SECNIDAZOLE TABLETS BP 1000 MG (14SECNOL (SECNIDADAZEL KIT EACH KIT CONT SECNIDAZOLE TABL | $2.0M | 12 | 6.7% |
| 4 | ATHENA DRUG DELIVERY SOLUTIONS PRIVATE LIMITED SECNIDAZOLE PELLETS (SECNIDAZOLE TASTE MSECNOL (SECNIDADAZEL KIT EACH KIT CONT SECNIDAZOLE TABL | $1.1M | 5 | 3.6% |
| 5 | CIPLA LIMITED CIPAZOL FORTE TABLETS | $697.5K | 1 | 2.3% |
| 6 | IMPACT HEALTHCARE PRIVATE LIMITED SECNOL (SECNIDADAZEL KIT EACH KIT CONT SECNIDAZOLE TABL | $673.4K | 8 | 2.2% |
| 7 | UNICHEM LABORATORIES LIMITED SECNIDAZOLE TABLETS BP 1000 MG (14PHARMACEUTICAL PRODUCTS : SENIDOL SECNIDAZOLE TABLETS 1GMADAY KIT TABLET KITPCS | $459.3K | 8 | 1.5% |
| 8 | NIYA HEALTHCARE PRIVATE LIMITED SECNOL (SECNIDADAZEL KIT EACH KIT CONT SECNIDAZOLE TABL | $323.3K | 1 | 1.1% |
| 9 | THE MADRAS PHARMACEUTICALS SECNIDAZOLE PELLETS (SECNIDAZOLE TASTE MSECNOL (SECNIDADAZEL KIT EACH KIT CONT SECNIDAZOLE TABL | $321.1K | 1 | 1.1% |
| 10 | KUSUM HEALTHCARE PRIVATE LIMITED | $295.3K | 7 | 1.0% |
| 11 | ZEST PHARMA SECNIDAZOLE TABLETS BP 1000 MG (14PHARMACEUTICAL PRODUCTS : SENIDOL SECNIDAZOLE TABLETS 1GMADAY KIT TABLET KITPCS | $192.9K | 6 | 0.6% |
| 12 | ALICE PHARMA PRIVATE LIMITED SECNOL (SECNIDADAZEL KIT EACH KIT CONT SECNIDAZOLE TABL | $187.1K | 2 | 0.6% |
| 13 | TRIDENT LIFELINE LIMITED PHARMACEUTICAL PRODUCTS : SENIDOL SECNIDAZOLE TABLETS 1GMAGISEC 1 GM SECNIDAZOLE TABLETS 1 GITRACONAZOLE + SECNIDAZOLE CAPSULES 33.33MG + 166.66MG | $152.5K | 2 | 0.5% |
| 14 | AGIO PHARMACEUTICALS LIMITED PHARMACEUTICAL PRODUCTS : SENIDOL SECNIDAZOLE TABLETS 1GMDAZEL KIT[EACH KIT CONT.SECNIDAZOLE TABLAGISEC 1 GM SECNIDAZOLE TABLETS 1 G | $150.7K | 2 | 0.5% |
| 15 | STRIDES PHARMA SCIENCE LIMITED SECNOL (SECNIDADAZEL KIT EACH KIT CONT SECNIDAZOLE TABL | $115.2K | 1 | 0.4% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Secnidazole exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Ajanta Pharma Limited | Not Listed | Yes, as of December | Not Listed | Not verified | WHO Public Inspection Report issued in December 2023 for Bharuch facility. (extr |
| Cipla Limited | Not Listed | Yes | Not Listed | Not verified | Listed among WHO GMP certified companies in India. |
| Strides Pharma Science Limited | Not Listed | Yes | Not Listed | Not verified | Listed among WHO GMP certified companies in India. |
| Unichem Laboratories | Not Listed | Not Listed | Yes | Not verified | Manufacturing facilities approved by European Union GMP. |
| Lincoln Pharmaceuticals Limited | Not Listed | Yes | Yes | Not verified | Khatraj facility received EU GMP certification in May 2020. |
| Akums Drugs and Pharmaceuticals Limited | Not Listed | Not Listed | Yes | Not verified | Two units in Haridwar granted EU GMP certification. |
| Intas Pharmaceuticals | Not Listed | Not Listed | Yes | Not verified | Biologics unit certified as EU GMP-compliant in April 2007. |
TransData Nexus reviewed the regulatory standing of 7 leading Secnidazole exporters from India. 0 hold US FDA facility approvals, 4 maintain WHO-GMP certification, and 4 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Secnidazole sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as "Genome Valley," is a leading hub for pharmaceutical manufacturing and biotech research in India. The city hosts major companies like Dr. Reddy’s Laboratories and Aurobindo Pharma, contributing significantly to the production of active pharmaceutical ingredients (APIs) and bulk drugs. This robust infrastructure positions Hyderabad as a critical player in the supply chain for drugs like Secnidazole.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. Companies such as Lincoln Pharmaceuticals Limited, headquartered in Ahmedabad, exemplify this specialization. Established in 1979, Lincoln Pharmaceuticals has expanded its reach to over 80% of the domestic market by 2000 and has been listed on the National Stock Exchange of India since 2015. The company's manufacturing facilities in Ahmedabad and Mehsana are certified by ISO 9001:2015 and WHO cGMP, underscoring the region's commitment to quality in pharmaceutical formulations.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt in Maharashtra serves as a pivotal export gateway for pharmaceuticals. This region's strategic location and well-developed port infrastructure facilitate the export of pharmaceutical products to global markets. Companies like Ajanta Pharma Limited, headquartered in Mumbai, leverage this advantage. Established in 1973, Ajanta Pharma has a presence in over 30 countries and operates seven manufacturing facilities in India, including those in Dahej and Paithan approved by the US FDA. The company's focus on branded generic formulations across various therapeutic areas highlights the region's role in catering to international demand.
4Baddi-Nalagarh — Tax Incentive Zone
The Baddi-Nalagarh region in Himachal Pradesh has emerged as a significant pharmaceutical hub, primarily due to favorable tax incentives. This area hosts numerous pharmaceutical manufacturing units, contributing to the production of a wide range of drugs. The region's growth is supported by government initiatives aimed at strengthening pharmaceutical clusters and MSMEs, with a total financial outlay of Rs. 500 crore for the period from FY 2021-22 to FY 2025-26.
5Sourcing Recommendations
- Diversify Supplier Base: Given that the top five exporters account for 84.6% of Secnidazole shipments, it's advisable to engage with a broader range of suppliers to mitigate risks associated with over-reliance on a few sources.
- Evaluate Supplier Credentials: Prioritize suppliers with certifications such as WHO cGMP and ISO 9001:2015 to ensure product quality and regulatory compliance.
- Leverage Export Hubs: Utilize the logistical advantages of regions like Mumbai-Thane-Raigad for efficient export operations, benefiting from established infrastructure and proximity to major ports.
- Monitor Regulatory Developments: Stay informed about government initiatives and incentives in pharmaceutical clusters to capitalize on emerging opportunities and maintain compliance with evolving regulations.
By strategically engaging with India's diverse pharmaceutical clusters and adhering to these recommendations, stakeholders can optimize their sourcing strategies for Secnidazole and other pharmaceutical products.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Secnidazole exporters from India
Cipla Limited — Cipla acquires Ivia Beaute's cosmetics and personal care business
In April 2024, Cipla Limited acquired the cosmetics and personal care distribution and marketing business of Ivia Beaute Pvt Ltd for ₹130 crore. - IMPACT: This acquisition is not directly related to Secnidazole exports and is unlikely to impact Cipla's position in that market.
Impact: This acquisition is not directly related to Secnidazole exports and is unlikely to impact Cipla's position in that market.
Lincoln Pharmaceuticals Limited — Lincoln Pharma receives EU GMP certification for Khatraj facility
In May 2020, Lincoln Pharmaceuticals Limited received European Union Good Manufacturing Practice (EU GMP) certification for its Khatraj facility, enabling the company to export to European markets. - IMPACT: This certification may enhance Lincoln Pharmaceuticals' export capabilities, potentially affecting its Secnidazole export volumes.
Impact: This certification may enhance Lincoln Pharmaceuticals' export capabilities, potentially affecting its Secnidazole export volumes.
Lincoln Pharmaceuticals Limited — Lincoln Pharma obtains Australia's TGA certification for Gujarat plant
In October 2021, Lincoln Pharmaceuticals Limited received Therapeutic Goods Administration (TGA) certification from Australia for its Gujarat manufacturing plant, allowing exports to the Australian market. - IMPACT: This approval may expand Lincoln Pharmaceuticals' export opportunities, potentially influencing its Secnidazole export performance.
Impact: This approval may expand Lincoln Pharmaceuticals' export opportunities, potentially influencing its Secnidazole export performance.
Common Questions — Secnidazole Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which secnidazole supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, CAPLIN POINT LABORATORIES LIMITED leads with 42 recorded shipments worth $16.4M. LINCOLN PHARMACEUTICALS LTD (19 shipments) and AJANTA PHARMA LIMITED (90 shipments) are also established high-volume exporters.
Q How many secnidazole manufacturers are there in India?
India has 115 active secnidazole exporters with a combined export market of $30.3M across 652 shipments to 77 countries. The top 5 suppliers hold 84.6% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for secnidazole from India?
Average FOB unit price: $31.01 per unit, ranging from $0.02 to $16206.16. Average shipment value: $46.5K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 115 verified Indian exporters of Secnidazole ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 652 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 77 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
652 Verified Shipments
115 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists